dc.contributor.author | Corazza, Ornella | |
dc.contributor.author | Schifano, Fabrizio | |
dc.contributor.author | Farre, Magi | |
dc.contributor.author | Deluca, Paolo | |
dc.contributor.author | Davey, Zoe | |
dc.contributor.author | Drummond, Colin | |
dc.contributor.author | Torrens, Marta | |
dc.contributor.author | Demetrovics, Zsolt | |
dc.contributor.author | Di Furia, Lucia | |
dc.contributor.author | Flesland, Liv | |
dc.contributor.author | Mervo, Barbara | |
dc.contributor.author | Moskalewicz, Jacek | |
dc.contributor.author | Pisarska, Agnieszka | |
dc.contributor.author | Shapiro, Harry | |
dc.contributor.author | Siemann, Holger | |
dc.contributor.author | Skutle, Arvid | |
dc.contributor.author | Pezzolesi, Cinzia | |
dc.contributor.author | van der Kreeft, Peer | |
dc.contributor.author | Scherbaum, Norbert | |
dc.date.accessioned | 2013-04-18T10:54:33Z | |
dc.date.available | 2013-04-18T10:54:33Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Corazza , O , Schifano , F , Farre , M , Deluca , P , Davey , Z , Drummond , C , Torrens , M , Demetrovics , Z , Di Furia , L , Flesland , L , Mervo , B , Moskalewicz , J , Pisarska , A , Shapiro , H , Siemann , H , Skutle , A , Pezzolesi , C , van der Kreeft , P & Scherbaum , N 2011 , ' Designer drugs on the Internet : a phenomenon out-of-control? The emergence of hallucinogenic drug Bromo-Dragonfly ' , Current Clinical Pharmacology , vol. 6 , no. 2 , pp. 125-129 . https://doi.org/10.2174/157488411796151129 | |
dc.identifier.issn | 1574-8847 | |
dc.identifier.other | ORCID: /0000-0001-7371-319X/work/98163938 | |
dc.identifier.uri | http://hdl.handle.net/2299/10464 | |
dc.description | Copyright Bentham Science Publishers | |
dc.description.abstract | Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2- b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon | en |
dc.format.extent | 4 | |
dc.format.extent | 335734 | |
dc.language.iso | eng | |
dc.relation.ispartof | Current Clinical Pharmacology | |
dc.subject | ABDF | |
dc.subject | Bromo-Dragonfly | |
dc.subject | FLY-compounds | |
dc.subject | Internet monitoring | |
dc.subject | phenethylamines | |
dc.subject | designer drugs | |
dc.subject | ReDNet project | |
dc.subject | research chemicals | |
dc.subject | psychoactive drugs | |
dc.title | Designer drugs on the Internet : a phenomenon out-of-control? : The emergence of hallucinogenic drug Bromo-Dragonfly | en |
dc.contributor.institution | Health & Human Sciences Research Institute | |
dc.contributor.institution | Department of Pharmacy | |
dc.contributor.institution | Centre for Clinical Practice, Safe Medicines and Drug Misuse Research | |
dc.contributor.institution | Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Unit | |
dc.contributor.institution | Department of Clinical, Pharmaceutical and Biological Science | |
dc.contributor.institution | Centre for Future Societies Research | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.2174/157488411796151129 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |